The Christie NHS FT Annual Report & Accounts 2019-20

The Christie NHS Foundation Trust Annual Report & Accounts 2019-20

Yearly position

National targets and minimum standards

Threshold 2019/20 Q1 Q2 Q3 Q4

Target

32

Number of Attributable C-Diff cases Number of MRSA Bacteraemia

31

7 0

6 0

13

6 0

0

0

0

Infection control

100% 96.7%

MRSA Screening

100% 100% 100% 100% 100% 96% 96.9% 95.3% 97.6% 96.9%

% of cancer patients waiting a maximum of 31 days for diagnosis to first definitive treatment % of cancer patients waiting a maximum of 31 days for subsequent treatment (anti- cancer drugs) % of cancer patients waiting a maximum of 31 days for subsequent treatment (surgery) % of cancer patients waiting a maximum of 31 days for subsequent treatment (radiotherapy) % of cancer patients waiting a maximum of 62 days from GP referral to first definitive treatment including rare and testicular cancers (based on national allocated position). % of cancer patients waiting a maximum of 62 days from screening referral to first definitive treatment (based on national allocated position)

99.7%

98% 99.7% 99.7% 99.7% 99.8%

98.8%

94% 99.6% 98.1% 99.4% 98.3%

99.4%

94% 99.5% 99.5% 99.8% 98.8%

Cancer Targets

78.9%

85% 76.8% 77.0% 79.4% 82.5%

87.0%

90% 94.1% 70.0% 95.2% 89.5%

98.4% 99.9%

18 Weeks

18 week incomplete pathways

92% 98.3% 98.0% 99.0% 98.4% 99% 100.0% 100.0% 100.0% 99.4%

6 Weeks diagnostic waits

Maximum 6 week wait for diagnostic procedures

97